switching from compounded semaglutide to ozempic Wegovy Ozempic: GLP-1 Options Explained Seattle weight loss patients fret
Description
Karen L Jones, Endocrine and Metabolic Unit, Royal Adelaide Hospital, Adelaide, SA 5000, Australia
Read the full breakdown in what the FDA's July 30 deadline means for compounded semaglutide
They also have endometriosis
Example: If a patient started therapy at BMI 37 and now has BMI 31 after successful treatment, the provider may attest to the BMI at initiation if documented appropriately
Turns out her compounded version was a higher concentration than she realizedshed actually been taking 1.5x her intended dose
Our current practice is to consider a ~20% bolus insulin decrease and a ~10% basal insulin decrease before GLP-1RA initiation, although prior A1c, risk of hypoglycemia, potential risk of ketosis due to reduced insulin doses, as well as other patient-specific factors should guide the final insulin dose changes
